Farid Adrienne
Insider CIK 1867310 · IPSC Chief Operations Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IPSC Century Therapeutics, Inc. | S Sale | 2025-06-09 | 2025-06-11 | 552 | $0.62 | $342 | 250,141 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2025-05-05 | 2025-05-07 | 1,024 | $0.55 | $563 | 250,693 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2025-03-11 | 2025-03-12 | 120,000 | — | $0 | 120,000 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award | 2025-03-11 | 2025-03-12 | 120,000 | — | $0 | 251,717 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 2,359 | $0.62 | $1.5K | 131,717 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-05 | 1,054 | $0.78 | $822 | 134,076 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2024-11-04 | 2024-11-05 | 1,033 | $1.23 | $1.3K | 135,130 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2024-08-05 | 2024-08-07 | 1,073 | $1.83 | $2.0K | 136,163 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2024-05-03 | 2024-05-07 | 913 | $3.11 | $2.8K | 137,236 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise deriv | 2024-03-07 | 2024-03-08 | 22,831 | — | $0 | 168,655 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-11 | 146,000 | — | $0 | 146,000 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2024-03-07 | 2024-03-08 | 22,831 | $5.14 | $117.4K | 114,149 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise | 2024-03-07 | 2024-03-08 | 22,831 | $1.03 | $23.5K | 136,980 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award | 2024-03-07 | 2024-03-11 | 24,000 | — | $0 | 138,149 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise deriv | 2024-03-06 | 2024-03-08 | 30,684 | — | $0 | 191,486 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise | 2024-03-06 | 2024-03-08 | 30,684 | $1.03 | $31.6K | 144,833 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2024-03-06 | 2024-03-08 | 30,684 | $4.96 | $152.2K | 114,149 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise deriv | 2024-02-16 | 2024-02-21 | 485 | — | $0 | 222,170 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise | 2024-02-16 | 2024-02-21 | 485 | $1.03 | $500 | 114,634 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2024-02-16 | 2024-02-21 | 485 | $4.86 | $2.4K | 114,149 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2024-02-06 | 2024-02-07 | 1,784 | $4.49 | $8.0K | 114,149 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2024-02-05 | 2024-02-07 | 2,035 | $3.84 | $7.8K | 115,933 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2023-02-02 | 2023-02-06 | 131,250 | — | $0 | 131,250 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2023-02-02 | 2023-02-06 | 131,250 | — | $0 | 131,250 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award | 2023-02-02 | 2023-02-06 | 21,875 | — | $0 | 96,093 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award | 2023-02-02 | 2023-02-06 | 21,875 | — | $0 | 117,968 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 105,000 | — | $0 | 105,000 | SEC↗ |